Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Immunotherapy + Chemotherapy for Cervical Cancer
Recruiting1 awardPhase 3
Hamilton, Ontario
This trial is testing whether the immunotherapy drug pembrolizumab, when combined with standard chemotherapy, is more effective at treating cervical cancer than chemotherapy alone. The study will also look at the safety of the two treatments.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.